IMMUNOVEC
ImmunoVec develops gene therapy treatments to cure terminal genetic diseases of the immune system. Its gene therapy is intended for hematopoietic diseases.
IMMUNOVEC
Industry:
Biotechnology Genetics Health Care Medical
Founded:
2019-01-01
Address:
Santa Monica, California, United States
Country:
United States
Website Url:
http://www.immunovec.com
Status:
Active
Total Funding:
4.3 M USD
Similar Organizations
Calimmune
Calimmune is a clinical-stage gene therapy company.
Cure Forward
Cure Forward helps cancer patients and physicians access advanced treatments in oncology.
DalCor Pharmaceuticals
DalCor is developing precision treatments for cardiovascular disease by genetically targeting patients that will derive clinical benefits
Editas Medicine
Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics.
KayoThera
KayoThera develops therapeutics used to cure late-stage and metastatic cancers.
Kytopen
Kytopen developer of a cell therapy platform for non-viral delivery of molecules into hard-to-transfect immune cells.
Pathway Genomics
Pathway Genomics is a CAP accredited global clinical lab offering genetic tests for cancer risk, drug responses, and other conditions.
Current Employees Featured
Founder
Official Site Inspections
http://www.immunovec.com
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.107
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "ImmunoVec"
Home | immunoVec
At immunoVec we are developing life-saving gene therapy treatments that cure terminal genetic diseases of the immune system. Home: About Us ©2020 by immunoVec.See details»
ImmunoVec - Crunchbase Company Profile & Funding
Organization. ImmunoVec . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ... ImmunoVec develops gene therapy treatments …See details»
ImmunoVec - LinkedIn
ImmunoVec Biotechnology Research Los Angeles, California 1,483 followers Developing next generation cell and gene therapiesSee details»
ImmunoVec 2025 Company Profile: Valuation, Funding & Investors …
ImmunoVec General Information Description. Developer of a gene therapy intended for hematopoietic diseases. The company offers gene therapy treatments that cure terminal …See details»
Immunovec, Inc. Company Profile | Santa Monica, CA
Find company research, competitor information, contact details & financial data for Immunovec, Inc. of Santa Monica, CA. Get the latest business insights from Dun & Bradstreet.See details»
ImmunoVec - Funding, Financials, Valuation & Investors
ImmunoVec develops gene therapy treatments to cure terminal genetic diseases of the immune system. New. Resources. ... Experience the new Crunchbase, powered by AI . Experience the …See details»
ImmunoVec - Contacts, Employees, Board Members, Advisors
Organization. ImmunoVec . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 2. Contacts 9. About. …See details»
ImmunoVec - Company Profile - Tracxn
Feb 24, 2025 ImmunoVec - Developer of gene therapies for hematopoietic diseases. Raised a total funding of $4.3M over 1 round from 2 investors. Founded by Katelyn Masiuk and Ryan …See details»
Immunovec, Inc. Santa Monica, CA - filing information
May 4, 2020 Immunovec, Inc. is a business entity based in Santa Monica, CA. Established recently on May 4, 2020, this Unincorporated Association is recognized under the document …See details»
ImmunoVec - Incubating Companies - University of California, Los …
ImmunoVec has developed a platform for the generation of lentiviral vectors that are specifically engineered for each disease target. We are able to modify the patient’s own blood stem cells …See details»
IMMUNOVEC INC Santa Monica CA, 90401 - Company Profile
Free Business profile for IMMUNOVEC INC at 225 Arizona Ave, Santa Monica, CA, 90401-1210, US.See details»
immunoVec - Products, Competitors, Financials, Employees, …
About immunoVec. immunoVec focuses on developing gene therapy treatments for terminal genetic diseases within the hematopoietic system. The company offers solutions for genetic …See details»
ImmunoVec, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore ImmunoVec, Inc. with its drug pipeline, therapeutic area, technology platform, 1 literature, Disease Domain:Immune System Diseases, Hemic and Lymphatic ...See details»
EIN 85-0876916 - Immunovec, Inc., Santa Monica, California
The Employer Identification Number (EIN) for Immunovec, Inc. is 85-0876916. EIN numbers are also referred to as FEIN or FTIN. Find EIN, Contact Details for Immunovec, Inc.. Toggle …See details»
Ryan Wong - Executive Vice President of Research and ... - LinkedIn
Executive Vice President of Research and Development · ImmunoVec · University of California, Los Angeles · Los Angeles · 362 connections on LinkedIn. View Ryan Wong’s profile on …See details»
Feiyang Ma - Chief Technology Officer - ImmunoVec | LinkedIn
Jun 18, 2023 CTO at ImmunoVec · Experienced bioinformatician with broad knowledge in T cell/macrophage/stem cell biology and autoimmune/infectious disease immunology. Proven …See details»
ImmunoVec – CIRM - California
ImmunoVec. Return to Grants. Total Awards: 3. Award Value: $11,551,190. Institution type: For profit. Short Name: ImmunoVec. Awards to the Institution. Program Type Investigator Grant …See details»
ImmunoVec - Crunchbase
ImmunoVec develops gene therapy treatments to cure terminal genetic diseases of the immune system.See details»
ImmunoVec - Raised $4.3M Funding from 2 investors - Tracxn
Feb 24, 2025 ImmunoVec raised $4.3M in its latest funding round, which was Series A round held on Nov 05, 2021. How much funding has ImmunoVec raised till date? ImmunoVec has …See details»
Working at immunoVec - Glassdoor
Tell me about your organization skills . Answer question. See all 1 interviews. immunoVec FAQ. All answers shown come directly from immunoVec Reviews and are not edited or altered. ...See details»